IDiyas

For the Inventor, By the Inventor

Kyoto, Japan

Nippon Shinyaku Company, Ltd.


USPTO Granted Patents = 229



Trademarks = 15

Forward Citations = 2,235

Loading Chart...
Loading Chart...

320 inventors (with patents filed for the assignee):

goldMedal Hiroshi Enomoto (33 out of 35 patents)

silverMedal Shin'ichi Takeda (24 out of 27 patents)

bronzeMedal Yoshiaki Aoyagi (24 out of 24 patents)

4.  Yoshiaki Yoshikuni (20 out of 22 patents)

5.  Tetsuya Nagata (19 out of 108 patents)

6.  Naoki Watanabe (17 out of 19 patents)

7.  Shoichi Chokai (15 out of 15 patents)

8.  Hiromu Murai (15 out of 17 patents)

9.  Tadaaki Ohgi (14 out of 30 patents)

10.  Youhei Satou (13 out of 13 patents)

11.  Junzo Seki (13 out of 13 patents)

12.  Shingo Matsumura (13 out of 13 patents)

13.  Masahiro Kise (12 out of 12 patents)

14.  Katsuya Ohata (12 out of 15 patents)

15.  Yoji Ezure (11 out of 11 patents)


Core Competencies:
Azabenzimidazole Compounds
Antisense Oligonucleotides
Crystalline Substituted Pyrazines
PGI2 Receptor Agonists
Controlled-Release Preparation
JAK-Inhibiting Activity
Pyrazolothiazole Compound
Heterocyclic Derivative
Fibrosis Inhibitor
Morpholino Nucleic Acid Derivatives
Pharmaceutical Composition
Exon Skipping

229 patents:

1. 12448199 - Measuring container (2025-10-21),
2. 12319683 - Azabenzimidazole compounds and pharmaceutical (2025-06-03),
3. 12291710 - Antisense oligonucleotide targeting ATN1 mRNA or pre-mRNA (2025-05-06),
4. 12152009 - Crystalline substituted pyrazines as PGI2 receptor agonists (2024-11-26),
5. 12060556 - Antisense nucleic acids (2024-08-13),
6. 11981894 - Antisense nucleic acids (2024-05-14),
7. 11981499 - Loading tool and measuring container kit (2024-05-14),
8. 11781140 - Antisense nucleic acid inducing skipping of exon 51 (2023-10-10),
9. 11680055 - Crystals (2023-06-20),
10. 11655472 - Antisense nucleic acid that induces skipping of exon 50 (2023-05-23),
11. 11655218 - Crystalline substituted pyrazines as PGI2 receptor agonists (2023-05-23),
12. 11560401 - Method for preparing oligonucleic acid compound (2023-01-24),
13. 11382912 - Controlled-release preparation (2022-07-12),
14. 11377453 - Crystal of compound having JAK-inhibiting activity (2022-07-05),
15. 11193125 - Antisense nucleic acids (2021-12-07),
NIPPON SHINYAKU COMPANY, LTD. is a leading Japanese pharmaceutical company established in 1919. With a primary focus on developing innovative and reliable healthcare products, NIPPON SHINYAKU contributes to improving the well-being of people worldwide. The company's comprehensive portfolio includes prescription medicines, over-the-counter drugs, and health-related products. Through continuous research and development, NIPPON SHINYAKU aims to address various medical needs and provide effective solutions. For more information, please visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

229 Patents

#21 in Kyoto 615-0031

#618 in Japan

#3,615 in the World

...
Kyoto, Japan

Nippon Shinyaku Company, Ltd.

Forward Citations = 2,235

320 inventors:

goldMedal Hiroshi Enomoto (33 out of 35 patents)

silverMedal Shin'ichi Takeda (24 out of 27 patents)

bronzeMedal Yoshiaki Aoyagi (24 out of 24 patents)

4.  Yoshiaki Yoshikuni (20 out of 22 patents)

5.  Tetsuya Nagata (19 out of 108 patents)

Please report any incorrect information to support@idiyas.com
Loading…